XNAS
ISRG
Market cap146bUSD
Oct 08, Last price
415.41USD
1D
0.21%
1Q
2.12%
Jan 2017
489.54%
IPO
20,397.27%
Name
Intuitive Surgical Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Related entities
Subsidiaries (4)
INTUITIVE SURGICAL INTERNATIONAL FINANCE LLC
INTUITIVE SURGICAL OPERATIONS, INC.
INTUITIVE SURGICAL SÀRL
ABEX-EXCELENCIA ROBOTICA SL
Key people
Independent Chairman of the Board · since 2020
Chief Executive Officer, Director · since 2023
Executive Vice President, Chief Financial Officer, Head of Business Technology · since 2025
Bob DeSantis
Executive Vice President, Chief Strategy and Corporate Operations Officer · since 2023
Executive Vice President, Chief Medical Officer · since 2017
Mark Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer · since 2023
Henry Charlton
Executive Vice President, Chief Commercial and Marketing Officer · since 2025
Gary Loeb
Executive Vice President, Chief Legal and Compliance Officer · since 2025
Brian Miller
Head of Digital and AI Strategy · since 2026
David Rosa
Chief Executive Officer, Director · since 2025
Joseph Beery
Independent Director · since 2020
Independent Director · since 2024
Independent Director · since 2010
Independent Director · since 2023
Amy Ladd
Independent Director · since 2019
Independent Director · since 2016
Jami Nachtsheim
Independent Director · since 2017
Monica Reed
Independent Director · since 2021
IPO date
Jun 13, 2000
Employees
12,120
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
950 KIFER ROAD
SUNNYVALE, CA 94086
US
SUNNYVALE, CA 94086
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||